Your browser version may not work well with NCBI's Web applications. More information here...
1: Internist (Berl). 2008 Sep;49(9):1052-60.Click here to read Links

[Secondary prevention after myocardial infarction]

[Article in German]

Pflumm JE, Pomykaj T, Heintzen MP.

Medizinische Klinik 2, Städtisches Klinikum Braunschweig gGmbH, Salzdahlumer Strasse 90, Braunschweig, Germany.

A significant reduction in cardiovascular mortality has been achieved during the last decade. New techniques and materials for early coronary intervention have contributed significantly to reduce early mortality after myocardial infarction. Secondary prevention determines further progress; it combines evidence-based medical treatment as well as lifestyle modifications. ACE inhibitors, angiotensin receptor blockers, and beta-blocker positively affect elevated blood pressure, left ventricular remodeling, and electrical stability. Statins decrease LDL and increase HDL cholesterol. Acetylsalicylic acid and clopidogrel are indicated for antiplatelet therapy. Lifestyle modifications unite a diet rich in polyunsaturated fatty acids, moderate physical activity, weight reduction, and smoking cessation.

PMID: 18651118 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Clopidogrel (Plavix® )

    Clopidogrel is used to prevent strokes and heart attacks in patients at risk for these problems. Clopidogrel is in a class of medications called antiplatelet drugs. It works by helping to prevent harmful blood clots that...

  • Clopidogrel (Plavix, Ticlid, Persantine, ...)

    How do antiplatelet agents compare in acute coronary syndromes?

  • Source: AHFS Consumer Medication Information